CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $10,618,000 | -0.3% | 874 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $10,645,000 | -21.2% | 874 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $13,503,000 | +14.9% | 874 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $11,755,000 | -50.1% | 874 | -19.5% | 0.00% | -57.1% |
Q1 2021 | $23,576,000 | -2.7% | 1,086 | -32.2% | 0.01% | 0.0% |
Q4 2020 | $24,222,000 | +18.9% | 1,601 | 0.0% | 0.01% | +16.7% |
Q3 2020 | $20,372,000 | -25.6% | 1,601 | 0.0% | 0.01% | -14.3% |
Q2 2020 | $27,375,000 | +29.4% | 1,601 | 0.0% | 0.01% | +16.7% |
Q1 2020 | $21,148,000 | -84.4% | 1,601 | -80.2% | 0.01% | -76.0% |
Q4 2019 | $135,515,000 | -58.8% | 8,069 | -55.2% | 0.02% | -57.6% |
Q3 2019 | $329,233,000 | -23.5% | 18,014 | -10.0% | 0.06% | -21.3% |
Q2 2019 | $430,114,000 | +223.1% | 20,013 | +194.9% | 0.08% | +188.5% |
Q1 2019 | $133,109,000 | +42.3% | 6,787 | -5.7% | 0.03% | +52.9% |
Q4 2018 | $93,571,000 | -45.7% | 7,200 | 0.0% | 0.02% | -46.9% |
Q3 2018 | $172,376,000 | +25.1% | 7,200 | 0.0% | 0.03% | +39.1% |
Q2 2018 | $137,822,000 | – | 7,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |